Chemed (NYSE:CHE – Get Free Report) released its quarterly earnings data on Wednesday. The company reported $6.42 earnings per share for the quarter, missing the consensus estimate of $7.02 by ($0.60), FiscalAI reports. Chemed had a return on equity of 25.89% and a net margin of 11.02%.The business had revenue of $639.34 million for the quarter, compared to analyst estimates of $659.09 million. During the same quarter last year, the company earned $6.83 EPS. Chemed’s revenue was down .1% compared to the same quarter last year. Chemed updated its FY 2026 guidance to 23.250-24.250 EPS.
Chemed Price Performance
Shares of NYSE CHE traded down $1.70 during midday trading on Wednesday, reaching $466.62. 248,920 shares of the company traded hands, compared to its average volume of 165,709. The company has a market cap of $6.61 billion, a price-to-earnings ratio of 24.68, a PEG ratio of 2.33 and a beta of 0.44. The stock has a 50-day moving average price of $447.24 and a 200 day moving average price of $444.38. Chemed has a 52 week low of $408.42 and a 52 week high of $623.60.
Chemed Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Monday, February 23rd will be issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, February 23rd. Chemed’s dividend payout ratio (DPR) is 12.69%.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on Chemed
Institutional Trading of Chemed
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Los Angeles Capital Management LLC acquired a new stake in shares of Chemed in the 4th quarter worth approximately $26,000. Global Retirement Partners LLC raised its holdings in Chemed by 200.0% during the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after purchasing an additional 58 shares in the last quarter. Geneos Wealth Management Inc. lifted its position in Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares during the period. Employees Retirement System of Texas bought a new position in Chemed during the 3rd quarter valued at $64,000. Finally, Caitong International Asset Management Co. Ltd boosted its stake in Chemed by 5,333.3% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 163 shares of the company’s stock valued at $73,000 after purchasing an additional 160 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.
Chemed Company Profile
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Featured Articles
- Five stocks we like better than Chemed
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
